The cardiologists and vascular surgeons at the AMITA Health Heart & Vascular Institute work together as a cohesive, collaborative team, pushing each other to adapt the newest approaches and innovations so they can provide patients with leading-edge, comprehensive care. Care team members interact daily to share ideas, discuss clinical data, and get feedback from their colleagues.
As you know, patients with vascular disease often have the greatest heath care needs, with underlying issues that complicate the primary vascular complaint. Patients who are referred to the AMITA Health Vascular Surgery Program initially see a vascular specialist who conducts a full cardiovascular evaluation with appropriate screening. Results of this evaluation are then discussed by the entire care team to get diverse perspectives on the best plan of care for each patient. We invite the referring physician to participate in the decision-making process as well. Additionally, we take the time to educate the patient about his or her condition and the available options, as we believe that patient involvement leads to better outcomes.
The AMITA Health Heart & Vascular Institute offers a wide range of expertise and capabilities in-house, with no need for patients to be referred out. Vascular surgeons offer both venous and arterial procedures, including carotid endarterectomy, open aneurysm repairs, and lower and upper extremity bypasses, as well as endovascular approaches to aneurysm repair and carotid stenting. All vascular surgeons at the AMITA Health Heart & Vascular Institute are board-certified in vascular surgery and completed an additional two-year fellowship in both open and endovascular surgery. Interventional cardiologists in the Vascular Surgery Program also perform peripheral angiograms and angioplasties as well as sophisticated revascularization procedures.
The AMITA Health Heart & Vascular Institute has an active clinical trials program that brings the latest advances in vascular medicine directly to patients. Several trials in vascular medicine are actively recruiting patients (see box). The physicians at AMITA Health Heart & Vascular Institute are highly selective regarding participation in clinical trials, choosing only those trials that offer important options for patients and have the potential of improving outcomes. Patients who are eligible to participate in a clinical trial receive coordinated care and comprehensive support from both their clinical care team and the clinical research team.
Several new clinical trials in vascular medicine are planned for 2018, including studies with new devices and interventional procedures for peripheral arterial disease. The most current list of clinical trials underway at the AMITA Health Heart & Vascular Institute can be found at https://www.amitahealth.org/research.
The randomized OPTIMIZE trial is assessing the procedural and clinical value of the Svelte drug-eluting stent integrated delivery system (DES-IDS) and the DES-RX sirolimus-eluting coronary stent system for the treatment of atherosclerotic lesions.
Post-approval study of the RELAY thoracic stent-graft with Plus Delivery System in patients with thoracic aortic aneurysms and penetrating ulcers
Multinational, randomized study to assess the safety and effectiveness of lithoplasty in combination with drug-coated balloon (DCB) versus standard balloon angioplasty with DCB to treat moderate and severely calcified femoropopliteal arteries (above the knee)
A prospective, multicenter, single-arm observational study is also available for patients who do not meet the inclusion/exclusion criteria of the randomized study
Multinational, randomized study of the safety and efficacy of the SurVeil DCB for treatment of symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries
Multinational, randomized, double-blind placebo-controlled trial of rivaroxaban to reduce the risk of major thrombotic events in patients with symptomatic PAD undergoing lower extremity revascularization procedures